Active Ingredient: HYDROFLUMETHIAZIDE; RESERPINE
Proprietary Name: SALUTENSIN-DEMI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;0.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N012359
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SHIRE DEVELOPMENT INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
